The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations are being recognised increasingly. In this episode, we will review neuropsychiatric manifestations of COVID-19, and hear some preliminary results on the impact of COVID-19 on neurocognition and olfaction.
Chair: Professor Tom Solomon
Chair of Neurological Science, University of Liverpool, Director of the National Institute for Health Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections
Dr James J. Sejvar, Centers for Disease Control and Prevention, United States of America
Neuropsychiatric manifestations of COVID-19
Dr Lucette Cysique & Prof Bruce J. Brew, St Vincent’s Hospital Applied Medical Research Centre, Australia
“ADAPT” COVID-19 Study: A prospective, observational cohort study at St Vincent’s Hospital Sydney: preliminary neurocognitive and olfaction results
Brain Infections Global: An NIHR Global Health Research Group on Improving the Management of Acute Brain Infections